Chengjun Li
Impact in
-
- Spinal Cord Injury Research
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Extracellular vesicles in disease 12
- RNA Interference and Gene Delivery 4
-
- Spinal Cord Injury Research 14
- Co-authors
- Yong Cao (22 shared papers)Jianzhong Hu (23 shared papers)Hongbin Lü (25 shared papers)Liyuan Jiang (12 shared papers)Chunyue Duan (17 shared papers)Tian Qin (13 shared papers)Shawn S.‐C. Li (2 shared papers)Zhu Guo (4 shared papers)
- Journals
- Journal of Controlled Release (2 papers)Frontiers in Oncology (2 papers)Theranostics (2 papers)Scientific Reports (2 papers)Bioactive Materials (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Chengjun Li
61 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Pathology and Forensic Medicine 281
- Cancer Research 140
- Molecular Biology 602
- Developmental Neuroscience 33
- Immunology 174
Countries citing papers authored by Chengjun Li
This map shows the geographic impact of Chengjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengjun Li more than expected).
Fields of papers citing papers by Chengjun Li
This network shows the impact of papers produced by Chengjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengjun Li. The network helps show where Chengjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 135 | |
| 2 | 2002 | 80 | |
| 3 | 2003 | 76 | |
| 4 | 2001 | 68 | |
| 5 | 2020 | 62 | |
| 6 | 2023 | 56 | |
| 7 | 2019 | 55 | |
| 8 | 2005 | 55 | |
| 9 | 2022 | 48 | |
| 10 | 2016 | 41 | |
| 11 | 2023 | 40 | |
| 12 | 2023 | 36 | |
| 13 | 2016 | 31 | |
| 14 | Linoleic acid induces red blood cells and hemoglobin damage via oxidative mechanism. | 2015 | 29 |
| 15 | 2023 | 27 | |
| 16 | 2021 | 24 | |
| 17 | 2023 | 24 | |
| 18 | 2022 | 24 | |
| 19 | 2024 | 21 | |
| 20 | 2020 | 20 |
About Chengjun Li
Chengjun Li is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 65 papers that have together received 1.3k indexed citations. Recurring topics across this work include Spinal Cord Injury Research (14 papers), Extracellular vesicles in disease (12 papers), Sarcoma Diagnosis and Treatment (5 papers), MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (4 papers), Mesenchymal stem cell research (4 papers), Ferroptosis and cancer prognosis (4 papers) and Neurogenesis and neuroplasticity mechanisms (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (281 citations), Cancer Research (140 citations), Molecular Biology (602 citations), Developmental Neuroscience (33 citations) and Immunology (174 citations). Chengjun Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yong Cao, Jianzhong Hu, Hongbin Lü, Liyuan Jiang, Chunyue Duan, Tian Qin, Shawn S.‐C. Li, Zhu Guo, Jinyun Zhao and Zixiang Luo. Their work appears in journals such as Journal of Controlled Release, Frontiers in Oncology, Theranostics, Scientific Reports and Bioactive Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.